GB1262147A - Antimicrobial factors - Google Patents
Antimicrobial factorsInfo
- Publication number
- GB1262147A GB1262147A GB01397/69A GB1139769A GB1262147A GB 1262147 A GB1262147 A GB 1262147A GB 01397/69 A GB01397/69 A GB 01397/69A GB 1139769 A GB1139769 A GB 1139769A GB 1262147 A GB1262147 A GB 1262147A
- Authority
- GB
- United Kingdom
- Prior art keywords
- factor
- antimicrobial
- charcoal
- gel filtration
- elution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000004599 antimicrobial Substances 0.000 title abstract 4
- 239000003610 charcoal Substances 0.000 abstract 3
- 238000010828 elution Methods 0.000 abstract 3
- 238000002523 gelfiltration Methods 0.000 abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- 239000000284 extract Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 230000007935 neutral effect Effects 0.000 abstract 2
- ZXWQZGROTQMXME-DRXHHKTBSA-N 1-(beta-D-galactosyl)-N-[(2R)-2-hydroxylignoceroyl]sphingosine Chemical compound CCCCCCCCCCCCCCCCCCCCCC[C@@H](O)C(=O)N[C@H]([C@H](O)\C=C\CCCCCCCCCCCCC)CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O ZXWQZGROTQMXME-DRXHHKTBSA-N 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 244000052616 bacterial pathogen Species 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 229930183167 cerebroside Natural products 0.000 abstract 1
- 150000001784 cerebrosides Chemical class 0.000 abstract 1
- 230000002939 deleterious effect Effects 0.000 abstract 1
- 229940126534 drug product Drugs 0.000 abstract 1
- 238000000921 elemental analysis Methods 0.000 abstract 1
- 238000005194 fractionation Methods 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 210000005171 mammalian brain Anatomy 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 239000011347 resin Substances 0.000 abstract 1
- 229920005989 resin Polymers 0.000 abstract 1
- 210000000952 spleen Anatomy 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70986968A | 1968-03-04 | 1968-03-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1262147A true GB1262147A (en) | 1972-02-02 |
Family
ID=24851616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB01397/69A Expired GB1262147A (en) | 1968-03-04 | 1969-03-04 | Antimicrobial factors |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JPS5512412B1 (enrdf_load_stackoverflow) |
| DE (1) | DE1910715A1 (enrdf_load_stackoverflow) |
| FR (1) | FR2003203A1 (enrdf_load_stackoverflow) |
| GB (1) | GB1262147A (enrdf_load_stackoverflow) |
| NL (1) | NL6903238A (enrdf_load_stackoverflow) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8001748L (sv) * | 1980-03-05 | 1981-09-06 | Kaellenius Gunilla | Kompositioner for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutik |
| CA1168980A (en) * | 1980-04-17 | 1984-06-12 | Rolf Schafer | Wound healing compositions |
| WO1981003175A1 (en) * | 1980-05-09 | 1981-11-12 | H Leffler | Carbohydrate derivatives for inhibiting bacterial adherence |
| DK17885D0 (da) * | 1985-01-14 | 1985-01-14 | Karlsson Karl Anders | Antiviralt middel |
| US6001998A (en) * | 1994-11-10 | 1999-12-14 | Pfizer Inc | Macrocyclic lactone compounds and their production process |
-
1969
- 1969-03-03 NL NL6903238A patent/NL6903238A/xx unknown
- 1969-03-03 DE DE19691910715 patent/DE1910715A1/de active Pending
- 1969-03-04 FR FR6905873A patent/FR2003203A1/fr not_active Withdrawn
- 1969-03-04 GB GB01397/69A patent/GB1262147A/en not_active Expired
- 1969-03-04 JP JP1609269A patent/JPS5512412B1/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5512412B1 (enrdf_load_stackoverflow) | 1980-04-02 |
| NL6903238A (enrdf_load_stackoverflow) | 1969-09-08 |
| FR2003203A1 (fr) | 1969-11-07 |
| DE1910715A1 (de) | 1969-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL46201A (en) | 3-substituted 1,3-dihydrospiro(isobenzofuran-azacycloalkanes),their preparation and pharmaceutical compositions containing them | |
| IL44058A (en) | 3amino-1,2,4-benzotriazine 1,4-di-noxide derivatives, their preparation and compositions for the control of microorganisms containing them | |
| EG11468A (en) | Process for the preparation of sulphoxides and pharmaceutical compositions comprising them | |
| ES8402560A1 (es) | Procedimiento para la obtencion de nuevos derivados de omega-ciano-1,omega-difenil-aza-alcano. | |
| IL45938A0 (en) | Novel benzomorphane and morphinane derivatives,their preparation and pharmaceutical compositions containing them | |
| IE44431L (en) | Pyrimid-2-ones | |
| EP0011490A3 (en) | Analgesic tablet and process for its preparation | |
| GB1262147A (en) | Antimicrobial factors | |
| IL44626A (en) | 1-substituted pyrazol-5-ones processes for their preparation and pharmaceutical compositions containing some of these comounds | |
| GB1341794A (en) | Medicament for the treatment of hepatic disorders | |
| EG11068A (en) | New hydantion derivatives and compositions for plant-growth regulation | |
| GB1457546A (en) | Pharmaceutical preparations comprising cephalosporin derivatives | |
| IL60025A (en) | Process for the preparation of 1,3,7-tri substituted xanthines and certain new such xanthines and pharmaceutical compositions containing them | |
| AU552567B2 (en) | Oligopeptides with specific inhibiting properties of collageninduced aggregation, process for preparing the same and pharmaceutical compositions containing them | |
| IL59882A (en) | 3-(alkylamino-2-hydroxypropoxy)-6-(alkylidene hydrazino)pyridazine derivatives,process for their preparation and pharmaceutical compositions containing them | |
| GB828963A (en) | Pharmaceutical compositions containing 2-p-aminobenzenesulphonamido-5-t-butyl-1, 3, 4-thiadiazole | |
| GB1311015A (en) | Pharmaceutical compositions and a process for the manufacture thereof | |
| ES8100016A1 (es) | Procedimiento para la preparacion de nuevos derivados de 1-(4-aminopiperidino)-3,4-dihidroisoquinoleina. | |
| IL59619A0 (en) | Phthalazine derivatives,their preparation and pharmaceutical compositions containing them | |
| PH10103A (en) | 1)aryl-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin 2-ones derivatives,its pharmaceutical composition and process of preparation | |
| GB1363801A (en) | Peptides and their preparation | |
| GB1289039A (enrdf_load_stackoverflow) | ||
| GB1446237A (en) | Pharmaceutical preparations containing pyrazolones | |
| GB1269616A (en) | Improvements in pharmaceutical compositions | |
| IL44451A0 (en) | 1,2-diphenyl-ethane derivatives,processes for the preparation thereof and pharmaceutical composition containing the same |